跳到正文
原文
Gut 消化· Chang, Y.-P., Chen, Y.-C., Cheng, P.-N., Fang, Y.-J., Chen, C.-Y., Kao, W.-Y., Lin, C.-L., Yang, S.-S., Shih, Y.-L., Peng, C.-Y., Lee, F.-J., Tsai, M.-C., Huang, S.-C., Su, T.-H., Tseng, T.-C., Liu, C.-J., Chen, P.-J., Kao, J.-H., Liu, C.-H.·· 9 天前AI 评分40

MASLD 后肝硬化程度和糖代谢异常与 HCC 风险的关系

Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease

AI 导读

在代谢功能障碍相关脂肪肝病 (MASLD) 患者中,肝脂肪变性程度加重与 HCC 风险增加约两倍相关,而整体心血管代谢负担与 HCC 风险无关。仅糖代谢异常与 HCC 风险显著相关,这些关联在敏感性分析中仍然成立。

来源:Gut 消化 · gut.bmj.com